JRCT ID: jRCTs052240137
Registered date:26/09/2024
Analysis of blood glucose variability using continuous blood glucose monitoring in esophageal and gastric cancer patients planned for radical surgery
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Esophageal or gastric cancer cases planned for radical surgery |
Date of first enrollment | 26/09/2024 |
Target sample size | 60 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) | Continuous blood glucose monitoring preoperatively and postoperatively in esophageal and gastric cancer patients planned for radical surgery |
Outcome(s)
Primary Outcome | Preoperative and postoperative blood glucose trends (percentage of hyperglycemic and hypoglycemic time) in patients undergoing surgery for esophageal and gastric cancer |
---|---|
Secondary Outcome | Association between questionnaire results (symptoms) and blood glucose levels, association between nutritional intake status (method of intake, caloric intake, type of nutritional supplements) and blood glucose levels, and association between surgical technique (reconstruction method) and blood glucose levels. |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Cases of esophageal or gastric cancer planned for radical surgery. (1) histologically confirmed esophageal or gastric cancer (2) planned radical surgery (T: any, N: any, M: 0) (3) Dysphagia score: 0-2 (4) age: 20 years or older (5)ECOG performance status: 0-1 (6) no serious hepatic or renal dysfunction (7)Patient's written consent has been obtained |
Exclude criteria | Patients with (1) active multiple cancers (2) severe malabsorption (3) inflammatory bowel disease (4) diabetes requiring insulin therapy (5) allergy to Libresensor (6) extensive skin lesions, scars, infection, or edema, which make the application of the sensor difficult (7) taking pralidoxime methyl iodide (8) Cases deemed inappropriate by the physician (9) Patients with severe mental disorders |
Related Information
Primary Sponsor | Motoori Masaaki |
---|---|
Secondary Sponsor | Masashi Hirota |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Masashi Hirota |
Address | 3-1-56, Mandai Higashi, Sumiyoshi-ku, Osaka city, Osaka, Japan Osaka Japan 5588558 |
Telephone | +81-666921201 |
mhirota@gh.opho.jp | |
Affiliation | Osaka General Medical Center |
Scientific contact | |
Name | Masaaki Motoori |
Address | 3-1-56, Mandai Higashi, Sumiyoshi-ku, Osaka city, Osaka, Japan Osaka Japan 5588558 |
Telephone | +81-666921201 |
mmotoori@gh.opho.jp | |
Affiliation | Osaka General Medical Center |